Scandinavian Biolabs ApS: Financial statements 2022
CVR: 41170514
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Scandinavian Biolabs ApS (CVR 41170514) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,591,104 and a net result of DKK -2,515,828 compared with DKK -4,612,120 the year before. Equity in the 2022 report amounted to DKK -5,930,366. The company had 19 employees in the financial year.
- Gross Profit
- DKK 1,591,104
- Profit/Loss
- DKK -2,515,828
- Equity
- DKK -5,930,366
- Total Assets
- DKK 3,691,662
- Employees
- 19
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 1.6M | -2.5M | -5.9M | 19 |
| 2021 | - | -1.9M | -4.6M | -3.4M | 12 |
| 2020 | - | -1.1M | -1.8M | -1.7M | 2 |
Official annual report
Keep an eye on Scandinavian Biolabs ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Scandinavian Biolabs ApS has published its annual report for 2021. Gross profit came to DKK -1,883,463, and the net result was DKK -4,612,120.
About Scandinavian Biolabs ApS
Scandinavian Biolabs ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2020. The company is registered under the industry Engroshandel med parfumerivarer og kosmetik. The management consists of Niels Valdemar Lundsgaard Konradi. The board consists of Mitesh Jatania (chair), Anders Reckendorff, Pascar Paw Paramasivam and Samuel Meeker Kaplan. The company's owners include Niels Valdemar Lundsgaard Konradi, Anders Reckendorff and BLAZAR ApS. The company has 19 employees (2026). In 2025, the company reported a gross profit of DKK -13,841,560 and a net result of DKK -25,270,973 compared with DKK -8,773,342 the year before. Equity in the 2025 report amounted to DKK 31,549,921.